Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The ...

Nations Financial Group Inc. IA ADV trimmed its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 5.9% in the ...

The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...

So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...

Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...

At the town hall of the annual gathering of the American Association for the Advancement of Science, Trump’s name was largely ...

Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...

Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston Scientific Corp (NYSE:BSX), ...

Executive Vice President and Chief Financial Officer, Daniel J. Brennan, recently engaged in a series of stock transactions, according to a recent SEC filing. The transactions come as the company, now ...

Medtronic and Axonics — now part of Boston Scientific — have confidentially settled their long-running IP dispute.